Sentinel Lymph Node in Aged Endometrial Cancer Patients "The SAGE Study": A Multicenter Experience.

aged population elderly endometrial cancer indocyanine green lymphatic anatomy sentinel lymph node (SLN)

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2021
Historique:
received: 06 07 2021
accepted: 17 09 2021
entrez: 5 11 2021
pubmed: 6 11 2021
medline: 6 11 2021
Statut: epublish

Résumé

The incidence of endometrial cancer is increasing in elderly people. Considering that aging progressively affects lymphatic draining function, we aimed to define its impact on IGC uptake during SLN mapping. A multicenter retrospective cohort of endometrial cancer patients with apparently early-stage endometrial cancer undergoing complete surgical staging with SLN dissection was identified in four referral cancer centers from May 2015 to March 2021. Patients were classified in Group 1 (<65 years old) and Group 2 (≥65 years old). The primary endpoint was the assessment of the overall, bilateral, and unsuccessful SLN mapping in the two groups. Secondary outcomes were the evaluation of SLN anatomical distribution and the identification of predictors for mapping failure applying a logistic regression. A total of 844 patients were enrolled in the study (499 in Group 1 and 395 in Group 2). The overall detection rate, the successful bilateral mapping, and the mapping failure rate of the SLN were 93.8% Old age represents a risk factor for SLN mapping failure both intrinsically and in relation to the greater incidence of other independent risk factors such as LVSI, non-endometrioid histotype, and BMI. Surgeons should target the usual uptake along UPP during the SLN dissection in this subgroup of patients to minimize mapping failure and the consequent risk of surgical under-staging and adjuvant undertreatment.

Identifiants

pubmed: 34737952
doi: 10.3389/fonc.2021.737096
pmc: PMC8560967
doi:

Types de publication

Journal Article

Langues

eng

Pagination

737096

Informations de copyright

Copyright © 2021 Cianci, Rosati, Vargiu, Capozzi, Sozzi, Gioè, Gueli Alletti, Ercoli, Cosentino, Berretta, Chiantera, Scambia and Fanfani.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer LA declared a past co-authorship with the authors to the handling editor.

Références

Adv Drug Deliv Rev. 2021 Feb;169:63-78
pubmed: 33316347
Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:218-222
pubmed: 30731335
Ann Surg Oncol. 2016 Aug;23(8):2522-8
pubmed: 26905542
Int J Gynecol Cancer. 2009 Jul;19(5):879-83
pubmed: 19574777
Eur J Obstet Gynecol Reprod Biol. 2019 Nov;242:36-42
pubmed: 31550627
J Cancer Res Clin Oncol. 2021 Mar;147(3):845-852
pubmed: 32880752
Int J Gynecol Cancer. 2020 Mar;30(3):372-377
pubmed: 31996396
Lancet Oncol. 2017 Mar;18(3):384-392
pubmed: 28159465
Clin Transl Oncol. 2013 Aug;15(8):665-9
pubmed: 23359175
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Curr Pharm Des. 2019;25(22):2480-2490
pubmed: 31333115
Eur J Surg Oncol. 2010 Mar;36(3):298-303
pubmed: 19628364
World J Surg. 2019 Oct;43(10):2401-2419
pubmed: 31187247
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Updates Surg. 2021 Jun;73(3):1155-1167
pubmed: 32472402
Int J Gynecol Cancer. 2016 Feb;26(2):282-9
pubmed: 26745698
J Robot Surg. 2010 Aug;4(2):109-15
pubmed: 27628776
Cancer. 2001 Nov 15;92(10):2562-8
pubmed: 11745190
Int J Gynecol Cancer. 2020 Nov;30(11):1713-1718
pubmed: 32868384
Int J Gynaecol Obstet. 2009 May;105(2):109
pubmed: 19345353
Anticancer Res. 2012 May;32(5):1817-20
pubmed: 22593467
Gynecol Oncol. 2015 Jan;136(1):54-9
pubmed: 25450151
J Clin Oncol. 2014 Aug 20;32(24):2595-603
pubmed: 25071125
J Obstet Gynaecol. 2019 Aug;39(6):805-810
pubmed: 31001998
Eur J Surg Oncol. 2021 Aug;47(8):2142-2149
pubmed: 33820674
Cancer. 1999 Dec 15;86(12):2668-73
pubmed: 10594862
Int J Gynecol Cancer. 2016 Nov;26(9):1717-1721
pubmed: 27575633
Gynecol Oncol. 2017 Oct;147(1):18-23
pubmed: 28716308
Int J Radiat Oncol Biol Phys. 1997 Dec 1;39(5):1125-9
pubmed: 9392554
Int J Gynecol Cancer. 2019 May;29(4):651-668
pubmed: 30877144
Gynecol Oncol. 2019 Oct;155(1):34-38
pubmed: 31402166
Minerva Med. 2021 Feb;112(1):3-11
pubmed: 33205640
J Clin Oncol. 2009 Nov 10;27(32):5331-6
pubmed: 19805679
Gynecol Oncol. 2017 May;145(2):256-261
pubmed: 28196672
Oncology. 2013;85(3):168-72
pubmed: 24008766
Surgery. 2005 Jul;138(1):56-63
pubmed: 16003317
Int J Gynecol Cancer. 2015 May;25(4):637-44
pubmed: 25723778
Ann Surg Oncol. 2017 Jun;24(6):1667-1676
pubmed: 28008573
Ann Oncol. 2016 Jan;27(1):16-41
pubmed: 26634381
Gynecol Oncol. 2006 Jun;101(3):470-5
pubmed: 16413048
Gynecol Oncol. 2017 Nov;147(2):320-328
pubmed: 28802765
Am J Obstet Gynecol. 2016 Mar;214(3):350.e1-350.e10
pubmed: 26433173
Updates Surg. 2019 Sep;71(3):419-427
pubmed: 30659479
Gynecol Oncol. 2017 Oct;147(1):120-125
pubmed: 28751118
Aging Cell. 2015 Aug;14(4):582-94
pubmed: 25982749
Minerva Med. 2021 Feb;112(1):81-95
pubmed: 33104302
J Am Coll Surg. 2006 Dec;203(6):865-77
pubmed: 17116555
PLoS One. 2018 Apr 26;13(4):e0195877
pubmed: 29698418
J Natl Compr Canc Netw. 2018 Feb;16(2):170-199
pubmed: 29439178
Eur J Surg Oncol. 2016 Feb;42(2):166-75
pubmed: 26647302
CA Cancer J Clin. 2013 Jan;63(1):11-30
pubmed: 23335087

Auteurs

Stefano Cianci (S)

Department of Gynecologic Oncology and Minimally-invasive Gynecologic Surgery, Università degli studi di Messina, Policlinico G. Martino, Messina, Italy.

Andrea Rosati (A)

Department of Woman and Child Health and Public Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.

Virginia Vargiu (V)

Department of Gynecologic Oncology, Gemelli Molise, Campobasso, Italy.

Vito Andrea Capozzi (VA)

Department of Gynecology and Obstetrics, Università di Parma, Parma, Italy.

Giulio Sozzi (G)

Department of Gynecologic Oncology, Aziende di Rilievo Nazionale di Alta Specializzazione (ARNAS) Civico Di Cristina Benfratelli, Palermo, Italy.

Alessandro Gioè (A)

Department of Woman and Child Health and Public Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.

Salvatore Gueli Alletti (S)

Department of Woman and Child Health and Public Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.

Alfredo Ercoli (A)

Department of Gynecologic Oncology and Minimally-invasive Gynecologic Surgery, Università degli studi di Messina, Policlinico G. Martino, Messina, Italy.

Francesco Cosentino (F)

Department of Gynecologic Oncology, Gemelli Molise, Campobasso, Italy.
Department of Gynecologic Oncology, Università degli studi del Molise, Campobasso, Italy.

Roberto Berretta (R)

Department of Gynecology and Obstetrics, Università di Parma, Parma, Italy.

Vito Chiantera (V)

Department of Gynecologic Oncology, Aziende di Rilievo Nazionale di Alta Specializzazione (ARNAS) Civico Di Cristina Benfratelli, Palermo, Italy.
Department of Gynecologic Oncology, Università di Palermo, Palermo, Italy.

Giovanni Scambia (G)

Department of Woman and Child Health and Public Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
Department of Women and Child Health and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.

Francesco Fanfani (F)

Department of Woman and Child Health and Public Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
Department of Women and Child Health and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.

Classifications MeSH